Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/30zDyCs
via IFTTT